Claire Jansson-Knodell, MD: Treating Pregnant Women With Celiac Disease

Video

Pregnant women with celiac disease were not only at a higher risk of several pregnancy and delivery related complications, but also less likely to have a full-term uncomplicated delivery compared to the cohort without celiac disease.

Pregnant women with celiac disease are at an increased risk of a number of negative outcomes, including preeclampsia, placental diseases, obstetric complications, and small for gestational age offspring.

In data presented during the 2023 Digestive Disease Week (DDW) in Chicago, a team of investigators studied outcomes within this patient population.

In the retrospective cohort study, the investigators sued the National Inpatient Sample for all pregnant women who delivered babies between 2015-2019, which included 12 million delivers, 10,555 of which were from women with celiac disease.

The results show pregnant women with celiac disease were not only at a higher risk of several pregnancy and delivery related complications, but also less likely to have a full-term uncomplicated delivery (odds ratio [OR], 0.15; 95% confidence interval [CI], 0.09-0.26) compared to the cohort without celiac disease.

However, there was not much of a difference in maternal mortality between the 2 groups [n = 0; 0% vs n = 895; <0.1%; P = 0.7].

For offspring, babies of celiac moms were more likely to be small for gestational age (OR, 1.26; 95% CI, 1.01-1.57) and experience distress (OR, 1.29; 95% CI, 1.17-1.42) during delivery.

In an interview with HCPLive®, Claire Jansson-Knodell, MD, associate staff, Cleveland Clinic, explained what the advice is for pregnant women with celiac disease in an effort to reduce the risk of these types of outcomes.

Related Videos
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
Ghada Bourjeily, MD: Research Gaps on Sleep Issues During Pregnancy
John Winkelman, MD, PhD: When to Use Low-Dose Opioids for Restless Legs Syndrome
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
Jennifer Martin, PhD: Boosting CPAP Adherence in Women with Sleep Apnea
© 2024 MJH Life Sciences

All rights reserved.